Global Vertebroplasty and Kyphoplasty Market is valued approximately USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.5 % over the forecast period 2020-2027. Vertebral Compression Fracture (VCF) lead to back pain, depression, reduced physical activity, decreased lung capacity, and difficulty sleeping. This Vertebral Compression Fracture (VCF) can be treated with Vertebroplasty & Kyphoplasty, a minimally invasive, image guided surgical procedures. These procedures help the patient to regain the functional abilities and avoid further vertebral collapse, thus stabilize the fracture, restore heights and reduce deformities. The rising geriatric population coupled with in the prevalence of spinal injuries due to sport injury or vehicle accidents are the few factors responsible for growth of the market over the forecast period. For instance: according to AgeingAsia.org, the number of population aged 60 and above were 11,988,000 in 2019 and is expected to rise by 29,841,000 in 2050. Also, the total percentage of population aged 60 and above were 12.3% in 2019 and is expected to rise by 27.2 % in 2050. Similarly, the American geriatric population (65 years old or more) was 16% in 2018 and is anticipated to rise by 22 % of American geriatric population in 2050. Also, according to World Health Organization, around 1.35 million people are died every year due to road traffic crash. According to Statista, the number of deaths due to road accidents across India was 137.57 thousand in 2013 and has risen to 151.11 thousand fatalities in 2019. However, stringent regulatory framework is the major factor restraining the growth of global Vertebroplasty and Kyphoplasty market during the forecast period.


The regional analysis of global Vertebroplasty and Kyphoplasty market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the the increasing aging population, the presence of product approvals coupled with high demand for minimally invasive surgery to treat VCFs in this region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Medtronic
Medaid Inc.
Teknimed
Cardinal health
Johnson & Johnson (Depuy Synthes)
Joimax GmbH
Stryker Corporation
Atcomed
Lindare Medical
Globus Medical, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Vertebroplasty Devices
Kyphoplasty Devices

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year 2017, 2018
Base year 2019
Forecast period 2020 to 2027

Target Audience of the Global Vertebroplasty and Kyphoplasty Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors